Skip to main content
Watch Insiders
TXGHealthcare

10x Genomics Inc (TXG) Insider Trading

In the last 90 days, 6 10x Genomics Inc (TXG) insiders reported no open-market purchases and 11 sales totaling $12,242,976. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 22, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 22, 2026Shehnaaz SulimanDirectorSale5,723$81.19$464,668
Sep 22, 2026Serge SaxonovChief Executive OfficerSale25,000$81.22$2,030,563
Sep 9, 2026Adam TaichChief Financial OfficerSale46,388$64.57$2,995,473
Sep 3, 2026John R StuelpnagelDirectorSale20,000$61.75$1,235,072
Aug 26, 2026Serge SaxonovChief Executive OfficerSale10,486$63.69$667,901
Aug 24, 2026Serge SaxonovChief Executive OfficerSale18,545$63.02$1,168,775
Aug 24, 2026Adam TaichChief Financial OfficerSale17,166$63.02$1,081,853
Aug 24, 2026Benjamin J. HindsonSee RemarksSale13,818$63.02$870,860
Aug 24, 2026Shehnaaz SulimanDirectorSale2,207$63.65$140,478
Aug 14, 2026Sarah A. TeichmannDirectorSale7,551$57.25$432,279
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

TXG insider trading FAQ

Are TXG insiders buying or selling?
Over the last 90 days, TXG insiders were net sellers, reporting $0.00 of open-market purchases and $12,242,976 of sales.
When was the last TXG insider purchase?
No open-market insider purchase of 10x Genomics Inc stock was reported in the last 90 days.
Where does TXG insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that 10x Genomics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.